APA (7th ed.) Citation

Domenjo-Vila, E., Casella, V., Iwabuchi, R., Fossum, E., Pedragosa, M., Castellví, Q., . . . Meyerhans, A. (2023). XCR1+ DCs are critical for T cell-mediated immunotherapy of chronic viral infections. Cell reports (Cambridge), 42(2), 112123. https://doi.org/10.1016/j.celrep.2023.112123

Chicago Style (17th ed.) Citation

Domenjo-Vila, Eva, et al. "XCR1+ DCs Are Critical for T cell-mediated Immunotherapy of Chronic Viral Infections." Cell Reports (Cambridge) 42, no. 2 (2023): 112123. https://doi.org/10.1016/j.celrep.2023.112123.

MLA (9th ed.) Citation

Domenjo-Vila, Eva, et al. "XCR1+ DCs Are Critical for T cell-mediated Immunotherapy of Chronic Viral Infections." Cell Reports (Cambridge), vol. 42, no. 2, 2023, p. 112123, https://doi.org/10.1016/j.celrep.2023.112123.